FindTrial
Sign In

Evaluation of the Safety and Efficacy of Synthetic Bone Grafts

Clinical Efficacy and Satety of Nanosynt Synthetic Bone Grafting: a retrospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-9qzjbkj
Enrollment
Unknown
Registered
2025-09-22
Start date
2025-06-28
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaw, Edentulous

Interventions

This is a longitudinal, retrospective study whose sample will consist of patients who underwent surgical procedures using FGM Dental Group synthetic bone grafts between 2023 and 2025. To this end, the
V03.175.500

Sponsors

Universidade do Extremo Sul Catarinense
Lead Sponsor
FGM Dental Group
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 18 years of age; both sexes; who underwent bone grafting with Nanosynt® (FGM Dental Group) between 2023 and 2025; who have complete records in clinical records, including anamnesis data, medical records and pre- and post-operative radiographic examinations

Exclusion criteria

Exclusion criteria: Patients with uncontrolled systemic comorbidities that may interfere with bone regeneration, such as diabetes mellitus and osteoporosis

Design outcomes

Primary

MeasureTime frame
The main objective of this study is to determine the effectiveness of the bone substitute in bone formation, measured by clinical and imaging tests—

Secondary

MeasureTime frame
Determine bone quality based on the density observed in radiographic examinations, the stability of the implant installed after grafting and the presence of inflammation—

Countries

Brazil

Contacts

Public ContactEduarda Thiesen

Universidade do Extremo Sul Catarinense

duda15.thiesen@gmail.com+55 (48) 9623-3555

Outcome results

None listed

Source: REBEC (via WHO ICTRP)